Rnc Capital Management LLC Vertex Pharmaceuticals Inc Transaction History

Rnc Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$151.91 - $192.21 $169,987 - $215,082	-1,119 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$167.73 - $192.74 $17,611 - $20,237	-105 Reduced 8.58%	1,119 $216,000
Q2 2018 Jul 20, 2018	SELL	$145.72 - $169.96 $72,860 - $84,980	-500 Reduced 29.0%	1,224 $208,000
Q1 2018 Apr 11, 2018	SELL	$151.6 - $177.13 $31,836 - $37,197	-210 Reduced 10.86%	1,724 $281,000
Q4 2017 Jan 17, 2018	BUY	$137.28 - $155.55 $26,220 - $29,710	191 Added 10.96%	1,934 $290,000
Q3 2017 Oct 16, 2017	SELL	$148.13 - $162.24 $182,940 - $200,366	-1,235 Reduced 41.47%	1,743 $265,000
Q2 2017 Aug 22, 2017	BUY	N/A	2,978	2,978 $384,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Rnc Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Rnc Capital Management LLC with notifications on news.